Earlier this month, the House of Representatives passed the 21st Century Cures Act in a rare bi-partisan effort. The bill is meant to speed the development of lifesaving treatments, but critics warn it may also allow ineffective or even harmful drugs onto the market.
Many economists say that until the U.S. banking system regains some stability, the overall economy will continue to falter. An update on the viability of U.S banks, and new options being considered to restore confidence.
- David Wessel economics editor, The Wall Street Journal; author "In Fed We Trust"
- Jeff Arricale Vice President and Portfolio Manager, T. Rowe Price Financial Services Fund Inc.
- Gretchen Morgenson business columnist, The New York Times.
- Simon Johnson senior fellow, Peterson Institute for International Economics, professor, the Sloan School of Management at the M.I.T., and former economic counselor at the I.M.F. He is the co-author of "The Baseline Scenario: What Happened to the Global Economy and What We Can do About It" and the soon-to-be-released book "13 Bankers - The Wall Street Takeover and the Next Financial Meltdown."
Most Recent Shows
Secretly-recorded videos have reopened the fight over federal funding for Planned Parenthood. We examine new hurdles for the organization, the political response and the latest in the battle over abortion rights in the U.S.
A novel about Vivian, a young Irish girl sent by rail from a New York City tenement to Minnesota in the early 1900s. She was one of thousands of abandoned children sent to live with rural families for a better life. But not all ended up in loving homes.
An estimated 11 million Americans could see their disability benefits slashed next year if Congress fails to take action. The White House and Republican lawmakers have opposing solutions. Social Security's disability fund and how to keep the program solvent.